{
    "title": "Vir Biotech slumps to over 3-year low as flu prevention therapy fails trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12320705/Vir-Biotech-slumps-3-year-low-flu-prevention-therapy-fails-trial.html",
    "date": "2023-07-20",
    "keywords": [
        "therapy",
        "trial",
        "company",
        "antibody",
        "covid19",
        "nadeau",
        "development",
        "thursday",
        "companys",
        "type",
        "flu",
        "midstage",
        "biotechnology",
        "firm",
        "prominence",
        "sotrovimab",
        "partnership",
        "plc",
        "market",
        "capitalization",
        "trade",
        "failure",
        "dose",
        "reduction",
        "influenza",
        "illness",
        "studys",
        "analyst",
        "phil",
        "drop",
        "cash",
        "end",
        "quarter",
        "portfolio",
        "note",
        "hepatitis",
        "b",
        "data",
        "year",
        "hiv",
        "peer",
        "alnylam",
        "vertex",
        "reporting",
        "leo",
        "bengaluru",
        "editing",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}